Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

This publication has 23 references indexed in Scilit:

• -Lactamase Inhibition and In Vitro Activity of Sulbactam and Sulbactam/Cefoperazone
  Clinical Infectious Diseases, 1997
• Bacteremia Due to Acinetobacter baumannii: Epidemiology, Clinical Findings, and Prognostic Features
  Clinical Infectious Diseases, 1996
• An Outbreak of Multiresistant Acinetobacter baumanii in a University Hospital in São Paulo, Brazil
  Infection Control & Hospital Epidemiology, 1996
• Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features
  Clinical Microbiology Reviews, 1996
• Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam
  The Lancet, 1994
• Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore
  Antimicrobial Agents and Chemotherapy, 1994
• Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting
  Journal of Hospital Infection, 1993
• Effect of Sulbactam on Infections Caused by Imipenem-ResistantAcinetobacter calcoaceticusBiotypeanitratus
  The Journal of Infectious Diseases, 1993
• β-Lactamase inhibitors and Acinetobacter spp.
  Journal of Antimicrobial Chemotherapy, 1990
• Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6)
  Antimicrobial Agents and Chemotherapy, 1989